SCHEMBL6401969

SCHEMBL6401969

CC1(c2ccc(N3CC(CN)OC3=O)cc2F)CN(C(=O)OCc2ccccc2)C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CALML3 P27482 6/20 0.41
TMEM97 Q5BJF2 3/20 0.39
SIGMAR1 Q99720 3/20 0.39
HTR1A P08908 1/20 0.39
ADRA2A P08913 1/20 0.39
ADRA2B P18089 1/20 0.39
ADRA2C P18825 1/20 0.39
DRD1 P21728 1/20 0.39
HRH2 P25021 1/20 0.39
HTR1B P28222 1/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
HTR1E P28566 1/20 0.39
SLC6A4 P31645 1/20 0.39
HRH1 P35367 1/20 0.39
HTR2B P41595 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39
F10 P00742 1/20 0.38
MAOB P27338 3/20 0.38
MAOA P21397 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6401966 1.00 CALML3 (0.41) CALML3TMEM97SIGMAR1HTR1AADRA2A
SCHEMBL27373619 0.94 CALML3 (0.40) CALML3TMEM97SIGMAR1HTR1AADRA2A
SCHEMBL27372015 0.92 CALML3 (0.49) CALML3TMEM97SIGMAR1HTR1AADRA2A
SCHEMBL6399601 0.92 CALML3 (0.49) CALML3TMEM97SIGMAR1HTR1AADRA2A
SCHEMBL6396462 0.89 MAOA (0.52) CALML3F10MAOBMAOALMNA
SCHEMBL6397617 0.83 CALML3 (0.45) CALML3TMEM97SIGMAR1HTR1AADRA2C
SCHEMBL27364293 0.83 CALML3 (0.45) CALML3TMEM97SIGMAR1HTR1AADRA2C
SCHEMBL5417793 0.82 MAOB (0.53) CALML3F10MAOBMAOALMNA
SCHEMBL1498789 0.82 MAOB (0.53) CALML3F10MAOBMAOALMNA
SCHEMBL7830672 0.81 MAOB (0.44) CALML3F10MAOBMAOALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050054683-A1 Phenyloxazolidinones having a C-C bond to 4-8 membered heterocyclic rings HUTCHINSON DOUGLAS K (US) 2005-03-10 US disclosed
CN-1072222-C Phenyloxazolidinones having a C-C bond to 4-8 membered heterocyclic rings UPJOHN CO (US) 2001-10-03 CN disclosed
CN-1197457-A Phenyloxazolidinones having a C-C bond to a 4-8 membered heterocyclic ring UPJOHN CO (US) 1998-10-28 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054683-A1 Phenyloxazolidinones having a C-C bond to 4-8 membered heterocyclic rings CBR1, NCOR1, RCOR1 CALML3 3240/4885TMEM97 1329/4885SIGMAR1 39/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.